Longeveron Inc. (LGVN)

$2.11 -2.75% $-0.06 Healthcare

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

$30.30M

Dr. Joshua Michael Hare FACC, M.D.

18.00

Miami, FL

Feb 12, 2021

-0.24

$-8.86

3.86

4.18

-1,578.76%

-0.73

-0.00

0.95

25.35

4.18

-100.05%

-246.98%

Similar stocks (19)

Edgewise Therapeutics, Inc.

EWTX

$35.20 -0.37%
Uptrend

Keros Therapeutics, Inc.

KROS

$66.70 -2.13%
Uptrend

Erasca, Inc.

ERAS

$2.99 -3.86%
Uptrend

Larimar Therapeutics, Inc.

LRMR

$9.10 -2.05%
Neutral

C4 Therapeutics, Inc.

CCCC

$5.51 -6.29%
Downtrend

Generation Bio Co.

GBIO

$2.05 -5.96%
Downtrend

Nutriband Inc.

NTRB

$4.92 0.94%
Neutral

Kronos Bio, Inc.

KRON

$0.90 3.78%
Downtrend

Kezar Life Sciences, Inc.

KZR

$7.36 -1.06%
Downtrend

RenovoRx, Inc.

RNXT

$1.08 -6.87%
Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.64 0.91%
Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.15 -4.96%
Downtrend

Kiora Pharmaceuticals, Inc.

KPRX

$3.64 -2.54%
Downtrend

Forte Biosciences, Inc.

FBRX

$5.68 8.75%
Downtrend

ABVC BioPharma, Inc.

ABVC

$0.52 -1.16%
Downtrend

Revelation Biosciences, Inc.

REVB

$0.99 -5.05%
Downtrend

Pasithea Therapeutics Corp.

KTTA

$3.40 0.30%
Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.65 1.63%
Downtrend

Better Therapeutics, Inc.

BTTX

$0.00 0.00%
Downtrend